Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlyle (CG) Cash & Equivalents (2016 - 2025)

Carlyle (CG) has 15 years of Cash & Equivalents data on record, last reported at $2.2 billion in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 61.37% year-over-year to $2.2 billion; the TTM value through Sep 2025 reached $2.2 billion, up 61.37%, while the annual FY2024 figure was $1.3 billion, 12.1% down from the prior year.
  • Cash & Equivalents reached $2.2 billion in Q3 2025 per CG's latest filing, up from $1.3 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.5 billion in Q4 2021 and bottomed at $870.3 million in Q2 2023.
  • Average Cash & Equivalents over 5 years is $1.4 billion, with a median of $1.3 billion recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: soared 186.06% in 2021, then plummeted 44.9% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $2.5 billion in 2021, then crashed by 44.9% to $1.4 billion in 2022, then grew by 5.85% to $1.4 billion in 2023, then dropped by 12.1% to $1.3 billion in 2024, then surged by 75.49% to $2.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $2.2 billion in Q3 2025, $1.3 billion in Q2 2025, and $1.3 billion in Q4 2024.